Search research articles
Contact Us
Filters
Showing results (151-160 of 259) with videos related to
Page
of 26
Sort By:
Archives of Physical Medicine and Rehabilitation
|
January 13, 2006
A follow-up study of older adults with traumatic brain injury: taking into account decreasing length of stay
Jason E Frankel, Jennifer H Marwitz, David X Cifu, et al.
Current Protein & Peptide Science
|
October 9, 2002
Anthrax fusion protein therapy of cancer
Arthur E Frankel, Bayard L Powell, Nick S Duesbery, et al.
Human Pathology
|
December 8, 2014
Increased plasma d-2-hydroxyglutarate in isocitrate dehydrogenase 2-mutated blastic plasmacytoid dendritic cell neoplasm
Dinesh Rakheja, Franklin Fuda, Travis Vandergriff, et al.
Medical Research Archives
|
November 21, 2022
The Effects of an mRNA Covid-19 Vaccine Booster on Immune Responses in Cancer-Bearing Veterans
Arthur E Frankel, Tazio Capozzola, Raiees Andrabi, et al.
International Journal of Cancer
|
February 15, 1989
An anti-CD5 immunotoxin for chronic lymphocytic leukemia: enhancement of cytotoxicity with human serum albumin-monensin
A A Hertler, D M Schlossman, M J Borowitz, et al.
Leukemia Research
|
September 11, 2013
Human recombinant arginase I(Co)-PEG5000 [HuArgI(Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells
Rita Tanios, Amira Bekdash, Elias Kassab, et al.
Blood
|
November 14, 1997
Modulation of the apoptotic response of human myeloid leukemia cells to a diphtheria toxin granulocyte-macrophage colony-stimulating factor fusion protein
A E Frankel, P D Hall, C Burbage, et al.
Leukemia Research
|
July 1, 1997
Ricin fusion toxin targeted to the human granulocyte-macrophage colony stimulating factor receptor is selectively toxic to acute myeloid leukemia cells
C Burbage, E P Tagge, B Harris, et al.
Molecular Cancer Therapeutics
|
October 17, 2006
A urokinase-activated recombinant anthrax toxin is selectively cytotoxic to many human tumor cell types
Ralph J Abi-Habib, Ravibhushan Singh, Shihui Liu, et al.
Molecular Cancer Therapeutics
|
August 27, 2003
Growth factor receptor expression varies among high-grade gliomas and normal brain: epidermal growth factor receptor has excellent properties for interstitial fusion protein therapy
Tie Fu Liu, Stephen B Tatter, Mark C Willingham, et al.
Page
of 26
Search research articles
Search
Showing results (151-160 of 259) with videos related to
Sort By:
Page
of 26
Archives of Physical Medicine and Rehabilitation
|
January 13, 2006
A follow-up study of older adults with traumatic brain injury: taking into account decreasing length of stay
Jason E Frankel, Jennifer H Marwitz, David X Cifu, et al.
Current Protein & Peptide Science
|
October 9, 2002
Anthrax fusion protein therapy of cancer
Arthur E Frankel, Bayard L Powell, Nick S Duesbery, et al.
Human Pathology
|
December 8, 2014
Increased plasma d-2-hydroxyglutarate in isocitrate dehydrogenase 2-mutated blastic plasmacytoid dendritic cell neoplasm
Dinesh Rakheja, Franklin Fuda, Travis Vandergriff, et al.
Medical Research Archives
|
November 21, 2022
The Effects of an mRNA Covid-19 Vaccine Booster on Immune Responses in Cancer-Bearing Veterans
Arthur E Frankel, Tazio Capozzola, Raiees Andrabi, et al.
International Journal of Cancer
|
February 15, 1989
An anti-CD5 immunotoxin for chronic lymphocytic leukemia: enhancement of cytotoxicity with human serum albumin-monensin
A A Hertler, D M Schlossman, M J Borowitz, et al.
Leukemia Research
|
September 11, 2013
Human recombinant arginase I(Co)-PEG5000 [HuArgI(Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells
Rita Tanios, Amira Bekdash, Elias Kassab, et al.
Blood
|
November 14, 1997
Modulation of the apoptotic response of human myeloid leukemia cells to a diphtheria toxin granulocyte-macrophage colony-stimulating factor fusion protein
A E Frankel, P D Hall, C Burbage, et al.
Leukemia Research
|
July 1, 1997
Ricin fusion toxin targeted to the human granulocyte-macrophage colony stimulating factor receptor is selectively toxic to acute myeloid leukemia cells
C Burbage, E P Tagge, B Harris, et al.
Molecular Cancer Therapeutics
|
October 17, 2006
A urokinase-activated recombinant anthrax toxin is selectively cytotoxic to many human tumor cell types
Ralph J Abi-Habib, Ravibhushan Singh, Shihui Liu, et al.
Molecular Cancer Therapeutics
|
August 27, 2003
Growth factor receptor expression varies among high-grade gliomas and normal brain: epidermal growth factor receptor has excellent properties for interstitial fusion protein therapy
Tie Fu Liu, Stephen B Tatter, Mark C Willingham, et al.
Page
of 26